Hepatitis C trials that combine investigational agents with pegylated interferon should be stratified by interleukin-28B genotype.
Publication
, Journal Article
Thompson, AJ; Muir, AJ; Sulkowski, MS; Patel, K; Tillmann, HL; Clark, PJ; Naggie, S; Fellay, J; Ge, D; McCarthy, JJ; Goldstein, DB; McHutchison, JG
Published in: Hepatology
December 2010
Duke Scholars
Published In
Hepatology
DOI
EISSN
1527-3350
Publication Date
December 2010
Volume
52
Issue
6
Start / End Page
2243 / 2244
Location
United States
Related Subject Headings
- Recombinant Proteins
- Polyethylene Glycols
- Interleukins
- Interferons
- Interferon-alpha
- Interferon alpha-2
- Humans
- Hepatitis C
- Hepacivirus
- Gastroenterology & Hepatology
Citation
APA
Chicago
ICMJE
MLA
NLM
Thompson, A. J., Muir, A. J., Sulkowski, M. S., Patel, K., Tillmann, H. L., Clark, P. J., … McHutchison, J. G. (2010). Hepatitis C trials that combine investigational agents with pegylated interferon should be stratified by interleukin-28B genotype. Hepatology, 52(6), 2243–2244. https://doi.org/10.1002/hep.23826
Thompson, Alexander J., Andrew J. Muir, Mark S. Sulkowski, Keyur Patel, Hans L. Tillmann, Paul J. Clark, Susanna Naggie, et al. “Hepatitis C trials that combine investigational agents with pegylated interferon should be stratified by interleukin-28B genotype.” Hepatology 52, no. 6 (December 2010): 2243–44. https://doi.org/10.1002/hep.23826.
Thompson AJ, Muir AJ, Sulkowski MS, Patel K, Tillmann HL, Clark PJ, et al. Hepatitis C trials that combine investigational agents with pegylated interferon should be stratified by interleukin-28B genotype. Hepatology. 2010 Dec;52(6):2243–4.
Thompson, Alexander J., et al. “Hepatitis C trials that combine investigational agents with pegylated interferon should be stratified by interleukin-28B genotype.” Hepatology, vol. 52, no. 6, Dec. 2010, pp. 2243–44. Pubmed, doi:10.1002/hep.23826.
Thompson AJ, Muir AJ, Sulkowski MS, Patel K, Tillmann HL, Clark PJ, Naggie S, Fellay J, Ge D, McCarthy JJ, Goldstein DB, McHutchison JG. Hepatitis C trials that combine investigational agents with pegylated interferon should be stratified by interleukin-28B genotype. Hepatology. 2010 Dec;52(6):2243–2244.
Published In
Hepatology
DOI
EISSN
1527-3350
Publication Date
December 2010
Volume
52
Issue
6
Start / End Page
2243 / 2244
Location
United States
Related Subject Headings
- Recombinant Proteins
- Polyethylene Glycols
- Interleukins
- Interferons
- Interferon-alpha
- Interferon alpha-2
- Humans
- Hepatitis C
- Hepacivirus
- Gastroenterology & Hepatology